About: http://data.cimple.eu/news-article/e284661da1df50f48355750be59c6067901642389294659303d0cb35     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • British pharmaceutical giant GlaxoSmithKline (GSK) and Californian laboratory Vir Biotechnology on Tuesday announced final stage testing of their potential coronavirus treatment. The phase-three trials will evaluate the effectiveness of their "fully human anti-SARS-CoV-2 monoclonal antibody" VIR-7831 in the early treatment of patients at high risk of hospitalisation. If successful, the companies believe it could increase the number of people who have tested positive for the virus being treated as outpatients. GSK and Vir said in a joint statement the trials would take place in North America, South America and Europe after a "positive assessment of unblinded safety data". They will involve some 1,300 people, half of whom will receive a placebo, and the other half VIR-7831, with preliminary results available as early as the end of this year. Final results are likely in January next year. VIR-7831 is described as having "the potential to neutralise the virus, kill infected cells, provide a high barrier to resistance, and achieve high concentrations in the lungs". GSK announced in April that it is investing £350 million in the US laboratory and would work together to fight Covid-19 and any future possible outbreaks. ved/phz/ar/er
schema:headline
  • GSK and Vir step up virus antibody treatment trials
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...tology#hasEmotion
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software